The DOI matches its Crossref record.
Non‐surgical treatment of hepatocellular carcinoma
Abstract
A decade ago, surgery was the only satisfactory treatment modality for hepatocellular carcinoma (HCC), but it was limited only to selected cases. For the majority of cases of HCC, systemic chemotherapy was one of the few treatment alternatives, but provided only marginal benefit. In the past 20 years, diagnostic methods have improved to an extent that small HCC less than 1 cm can be detected. Moreover, non‐surgical treatment is available, of which regional therapy has been shown to prolong patients’ survival, and may even replace surgical resection in some cases. Regional therapy is indicated for the treatment of HCC when there is no extrahepatic metastasis and the patient has adequate liver function reserve, thus permitting repeated therapy. Transcatheter hepatic arterial embolization (TAE) using various embolizers has been well documented to include controlled studies. However, it is not indicated for patients with thrombosed main portal veins. Its therapeutic effect is also doubtful when the tumour is infiltrative in nature or is hypovascular, too large or too small. Additional chemotherapeutic agents mixed into the embolizer with lipiodol and degraded starch microspheres or styrene‐maleic acid‐neocarzinostatin in which chemotherapeutic agents are embedded, are used with a better response, but the survival rate has not shown significant improvement. Ultrasound‐guided local injection therapy is another new method of treatment of HCC. Of these techniques, percutaneous ethanol injection therapy (PEIT) is widely used with excellent results for small, encapsulated tumours in livers with less than three HCC. Percutaneous ethanol injection therapy can also be used in cases with portal vein thrombosis, but it is not suitable for patients having coagulopathy or ascites. Using acetic acid, OK‐432, interferon or anti‐cancer drugs in the injection therapy shows no further benefit over ethanol alone. Transcatheter echoguided thermotherapy or cryotherapy has been reported in small series of patients, as has target therapy with immune or radiotherapy and conformal radiotherapy. Preliminary studies show encouraging results. Systemic therapy with either single drug or multidrugs is ineffective, with a response rate of less than 20%. Immunotherapy, such as with interferon or other cytokines, is not beneficial. Hormone therapy has not been promising, except for treatment with tamoxifen, which has been reported to show some beneficial effect. Gene therapy is still in its infancy. In summary, recent progress in non‐surgical treatment of HCC has resulted in a breakthrough of regional therapy looking quite promising. Moreover, a combination of different types of regional therapies may yield better outcomes in selected individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis
Curley, S. A., Izzo, F., Ellis, L. M., Nicolas Vauthey, J., & Vallone, P. (2000) · Annals of Surgery · doi:10.1097/00000658-200009000-00010 · Cited by 731
Vogl, T. J., Straub, R., Eichler, K., Söllner, O., & Mack, M. G. (2004) · Radiology · doi:10.1148/radiol.2302020646 · Cited by 286
Wu, F., Wang, Z.-B., Chen, W.-Z., Zhu, H., Bai, J., Zou, J.-Z., Li, K.-Q., Jin, C.-B., Xie, F.-L., & Su, H.-B. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.02.026 · Cited by 278
Wu, F., Wang, Z.-B., Chen, W.-Z., Zou, J.-Z., Bai, J., Zhu, H., Li, K.-Q., Xie, F.-L., Jin, C.-B., Su, H.-B., et al. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2003.10.010 · Cited by 262
Strigari, L., Sciuto, R., Rea, S., Carpanese, L., Pizzi, G., Soriani, A., Iaccarino, G., Benassi, M., Ettorre, G. M., & Maini, C. L. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.075861 · Cited by 239
Metadata
- Authors
- LIN, D., LIN, S., & LIAW, Y.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 1997-10
- Volume
- 12
- Issue
- 9-10
- Pages
- S319-28
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2060889467
- Cited by
- 172
- References
- 0
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non‐surgical treatment of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1111/j.1440-1746.1997.tb00516.x
- The paper
- LIN, D., LIN, S., & LIAW, Y. (1997). Non‐surgical treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.1997.tb00516.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.